Nonrandomized comparison between docetaxel, CDDP and 5-FU (TPF) and docetaxel, CDDP and S-1 (TPS) in locally advanced squamous cell carcinoma of the head and neck (SCCHN)

被引：0
|
作者：
Nakanome, A. [1 ]
Okano, S. [1 ]
Wakasugi, T. [1 ]
Enokida, T. [1 ]
Yamazaki, T. [1 ]
Tahara, M. [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Head & Neck Med Oncol, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
316P
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [1] Locally advanced head and neck squamous cell carcinomas treated with TPF(docetaxel, cisplatin, 5-FU) induction chemotherapy
    Taguchi, Jun
    Shimizu, Yasushi
    Kinoshita, Ichiro
    Honma, Rio
    Takeuchi, Satoshi
    Tsuchiya, Kazuhiko
    Shirato, Hiroki
    Homma, Akihiro
    Fukuda, Satoshi
    Akita, Hirotoshi
    ANNALS OF ONCOLOGY, 2015, 26 : 90 - 90
  • [2] Concomitant chemoradiotherapy using docetaxel, cisplatin and 5-FU (TPF) for the patients with advanced squamous cell carcinoma of the head and neck.
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saitoh, Daisuke
    Oikawat, Shin-ichi
    Ikeda, Aya
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] CDDP AND 5-FU AFTER PRIOR VBM OR VBM AFTER PRIOR CDDP AND 5-FU IN THE MANAGEMENT OF RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    GRIMALDI, A
    MERLANO, M
    GARDIN, G
    ROSSO, R
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (12): : 1539 - 1540
  • [4] Results of a randomized phase II trial of docetaxel (TXT) with cisplatin (CDDP) or TXT with 5-fluorouracil (5FU) in patients (pts) with unresectable locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Biakhov, M
    Betka, J
    Shah, P
    Julka, P
    Garin, A
    Stanculaneu, D
    Kawecki, A
    Miserque, D
    Blanc, C
    ANNALS OF ONCOLOGY, 2000, 11 : 92 - 92
  • [5] Adjuvant docetaxel, cisplatin and 5-Fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck
    Baghi, M
    Hambek, M
    May, A
    Radeloff, A
    Gstoettner, W
    Knecht, R
    ANTICANCER RESEARCH, 2006, 26 (1B) : 559 - 563
  • [6] Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation versus concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori, R
    Tsukuda, M
    Ishitoya, J
    Kimura, M
    Hirose, S
    Takahashi, M
    Sakuma, Y
    Yamamoto, K
    Satoh, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 519S - 519S
  • [7] A phase II study of nimotuzumab and CDDP concurrent with radiation in locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Lim, Wan-Teck
    Ang, Mei-Kim
    Quan Sing Ng
    Wang, Lan-Ying
    Chau, Noan-Minh
    Tan, Daniel S. W.
    Chay, Wen Yee
    Leong, Swan
    Tan, Eng-Huat
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Phase I study of concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with unresectable locally advanced squamous cell carcinoma of head and neck (SCCHN).
    Tahara, M
    Minami, H
    Mukai, H
    Kawada, K
    Kawashima, M
    Ogino, T
    Yamazaki, M
    Matsuura, K
    Hayashi, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 518S - 518S
  • [9] Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Katori, H
    Tsukuda, M
    Mochimatu, I
    Ishitoya, J
    Kawai, S
    Mikami, Y
    Matsuda, H
    Tanigaki, Y
    Horiuchi, C
    Ikeda, Y
    Taguchi, T
    Ono, M
    Yoshida, T
    Hirose, S
    Sakuma, Y
    Yamamoto, K
    BRITISH JOURNAL OF CANCER, 2004, 90 (02) : 348 - 352
  • [10] Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Katori, Hideaki
    Tsukuda, Mamoru
    Watai, Kiichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (03) : 399 - 406
12345